13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 30 holding rows worth $625,361,199.
- Accession
- 0001104659-23-090491
- Filer
- CIK 1615982
- Filed
- 2023-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 30 entries on the cover page, a total value of $625,361,199 stated on the cover page (in dollars after the unit check, H1), rows summing to $625,361,199 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,082,622 | $73,335,577 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,684,132 | $55,460,123 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 3,000,000 | $54,210,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 2,230,127 | $45,516,892 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,726,214 | $45,451,215 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,517,125 | $41,730,688 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 2,484,960 | $40,902,442 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 2,916,667 | $26,250,003 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,972,869 | $26,012,604 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,973,251 | $25,474,670 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,173,913 | $24,456,521 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,105,386 | $23,117,138 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 6,351,531 | $20,293,142 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,326,200 | $20,078,668 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 1,090,000 | $17,974,100 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,142,856 | $16,628,563 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,040,754 | $10,792,619 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,422,397 | $8,179,529 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 5,658,034 | $7,242,284 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 770,000 | $7,184,100 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,208,812 | $6,295,114 | dollars as filed | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 3,886,246 | $6,179,131 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 5,304,410 | $6,100,072 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 288,949 | $5,235,756 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 924,170 | $3,798,339 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 6,343,221 | $2,857,621 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 353,629 | $1,785,826 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 268,532 | $1,519,891 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 1,428,571 | $854,571 | dollars as filed | |
| AVALO THERAPEUTICS INC COM NEW | 05338F207 | Stock | 1,250,000 | $444,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-090491 | this filing | 2023-08-11 | acceptance time not in the bulk data set |